ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
FDA Announces Voluntary Recall of Montelukast
americanpharmaceuticalreview
September 05, 2018The U.S. Food and Drug Administration (FDA) is warning consumers and health care professionals about a voluntary recall of one lot of Montelukast Sodium Tablets – lot number MON17384, expiration 12/31/2019 – by Camber Pharmaceuticals, Piscataway, N.J. -
Camber Pharmaceuticals Issues Voluntary Recall of Montelukast Tablets
newsnow
September 04, 2018The FDA is warning consumers and health care professionals about a voluntary recall of one lot of Montelukast Sodium Tablets lot number MON17384, expiration?12/31/2019 by Camber Pharmaceuticals, Inc.,?Piscataway, N.J.?Sealed bottles labeled as montelukast
Pharma Sources Insight January 2025
